https://european-biotechnology.net/wp-content/uploads/2025/11/bic_ingelheim-e1762275566553.webp408728Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-05-13 11:51:482026-05-13 11:51:48Millions for Preclinical Immunology: Boehringer Teams Up with Immunitas
https://european-biotechnology.net/wp-content/uploads/2026/05/micheile-henderson-ZVprbBmT8QA-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-05-12 11:44:422026-05-12 11:44:42Infex raises £4.3M for anti-infective R&D ahead of Phase 2a data on lead asset
https://european-biotechnology.net/wp-content/uploads/2026/05/getty-images-Nmd_5Q6jPGM-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-05-12 07:46:382026-05-12 07:46:38Tolemy Bio raises €1.4m to build AI control panel for cell biology
https://european-biotechnology.net/wp-content/uploads/2026/05/anirudh-djo3iNJpaOE-unsplash-1030x589-1.jpg5891030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-05-07 08:00:162026-05-07 08:00:16Scarlet raises £3.2 million to advance lab-grown red blood cell therapies
